Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...

Medtronic’s stock sat on the discount rack for years. Then, in August, a well-known activist investor finally took the bait, ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months.

Medtronic stock has seen its Fair Value Estimate climb modestly, rising from $98.63 to $99.90, with updates from sector ...

The U.S. Food and Drug Administration says Medtronic's diabetes business is back in compliance. The agency issued a warning letter in December 2021 that detailed concerns about how Medtronic handled ...

In just the last few years, diabetes technology has grown exponentially smarter. Top of mind now for many devicemakers is the creation of a truly closed-loop system for insulin delivery—a system often ...

Tuck-in acquisitions are a major part of the big medtech companies' strategies, especially at the likes of Medtronic and ...

Health tech company Medtronic is acquiring insulin patch pump company EOFlow for $738 million, the company announced Thursday. The acquisition is meant to bolster Medtronic’s diabetes offerings and ...

GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the ...

Medtronic is the world’s largest pure-play medical device company. It is a dividend aristocrat, conservatively financed and well diversified. It seems like a great long-term investment. The company ...

Medtronic says it has promising data on the effectiveness of its next-generation insulin pump from patients in Europe and Chile. The MiniMed 780G insulin pump, which was cleared in 2020 for use in ...